Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

BACKGROUND: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Public Health
Hlavní autoři: Ahmed, Mohammad Z., Zia, Qamar, Haque, Anzarul, Alqahtani, Ali S., Almarfadi, Omar M., Banawas, Saeed, Alqahtani, Mohammed S., Ameta, Keshav L., Haque, Shafiul
Médium: Artigo
Jazyk:Inglês
Vydáno: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871101/
https://ncbi.nlm.nih.gov/pubmed/33866129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.01.016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky